WECARELIFE
Live / Applied — Second extension granted (statement of use) (as of 16 Oct 2025)
What this means for you
Not registered yet, but its 02 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98338379
- Mark type
- Design + words
- Filed
- 02 Jan 2024
- Published for opposition
- 10 Sept 2024
- Attorney of record
- Bharati Bakshani
Goods and services
- Class 005 — Pharmaceuticals: Delivery agents in the form of nanoparticles that facilitate the delivery of nutritional supplements; Drug delivery agents in the form of nanoparticles that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes
Owner
- WeCareLife Biotech Co., Ltd., Daxing, Beijing, CN
- WeCareLife Biotech Co., Ltd., Daxing, Beijing, CN
Prosecution history
- 17 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Oct 2025 — SOU EXTENSION 2 GRANTED
- 16 Oct 2025 — SOU EXTENSION 2 FILED
- 16 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Apr 2025 — SOU EXTENSION 1 GRANTED
- 21 Apr 2025 — SOU EXTENSION 1 FILED
- 21 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Sept 2024 — PUBLISHED FOR OPPOSITION
- 21 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Jul 2024 — ASSIGNED TO EXAMINER
- 16 Apr 2024 — NOTICE OF DESIGN SEARCH CODE E-MAILED